NG-1 (Prana)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNG-1 (Prana)
Drug Alias Namenext generation metal-protein attenuating compounds (Prana)next generation MPACs (Prana)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChelating agents
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlterity Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlterity Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A